UTHR250117P300000
- 1.50
- 0.000.00%
United Therapeutics Newsroom
Here Are Updates on United Therapeutics Corp. (UTHR)
United Therapeutics(UTHR.US) Director Sells US$9.78 Million in Common Stock
$United Therapeutics(UTHR.US)$ Director SULLIVAN LOUIS W sold 26,209 shares of common stock on Dec 18, 2024 at an average price of $373.2197 for a total value of $9.78 million.Source: Announcement
United Therapeutics(UTHR.US) Officer Sells US$3.7 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer BENKOWITZ MICHAEL sold 10,000 shares of common stock on Dec 16, 2024 at an average price of $370.1377 for a total value of $3.7 million.Source: Announcement
United Therapeutics Announces Successful World's First UKidney Transplant
$1000 Invested In United Therapeutics 20 Years Ago Would Be Worth This Much Today
United Therapeutics(UTHR.US) Officer Sells US$3.68 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer BENKOWITZ MICHAEL sold 10,000 shares of common stock on Dec 9, 2024 at an average price of $367.6877 for a total value of $3.68 million.Source: Announcement
United Therapeutics (NASDAQ:UTHR) Has A Rock Solid Balance Sheet
United Therapeutics(UTHR.US) Officer Sells US$3.71 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer BENKOWITZ MICHAEL sold 10,000 shares of common stock on Dec 2, 2024 at an average price of $370.5074 for a total value of $3.71 million.Source: Announcement
The 3.8% Return This Week Takes United Therapeutics' (NASDAQ:UTHR) Shareholders Five-year Gains to 314%
United Therapeutics(UTHR.US) Officer Sells US$3.73 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer BENKOWITZ MICHAEL sold 10,000 shares of common stock on Nov 25, 2024 at an average price of $372.7547 for a total value of $3.73 million.Source: Announcement
How Is The Market Feeling About United Therapeutics?
United Therapeutics Insider Sold Shares Worth $2,828,672, According to a Recent SEC Filing
United Therapeutics(UTHR.US) Officer Sells US$3.59 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer BENKOWITZ MICHAEL sold 10,000 shares of common stock on Nov 18, 2024 at an average price of $359.2071 for a total value of $3.59 million.Source: Announcement
Form 144 | United Therapeutics(UTHR.US) Officer Proposes to Sell 14.53 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 18, $United Therapeutics(UTHR.US)$ Officer Michael Benkowitz intends to sell 40,000 shares of its common stock on Nov 18, with a total market value of approximately $14.53
Earnings Working Against United Therapeutics Corporation's (NASDAQ:UTHR) Share Price
United Therapeutics(UTHR.US) Officer Sells US$9.97 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer BENKOWITZ MICHAEL sold 25,000 shares of common stock on Nov 6, 7, 2024 at an average price of $398.8486 for a total value of $9.97 million.Source: Announcement
Form 144 | United Therapeutics(UTHR.US) Officer Proposes to Sell 15.31 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 6, $United Therapeutics(UTHR.US)$ Officer Michael Benkowitz intends to sell 40,000 shares of its common stock on Nov 6, with a total market value of approximately $15.31
United Therapeutics(UTHR.US) Director Sells US$3.82 Million in Common Stock
$United Therapeutics(UTHR.US)$ Director Giltner Richard sold 10,000 shares of common stock on Nov 5, 2024 at an average price of $381.7022 for a total value of $3.82 million.Source: Announcement
Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 3.82 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 5, $United Therapeutics(UTHR.US)$ Director RICHARD GILTNER intends to sell 10,000 shares of its common stock on Nov 5, with a total market value of approximately $3.82
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference